Development of pacemaker lead thrombosis in a patient with atrial fibrillation during apixaban treatment

dc.contributor.authorAdar, A.
dc.contributor.authorÖnalan, O.
dc.contributor.authorCakan, F.
dc.date.accessioned2024-09-29T16:16:27Z
dc.date.available2024-09-29T16:16:27Z
dc.date.issued2019
dc.departmentKarabük Üniversitesien_US
dc.description.abstractApixaban was introduced in clinical use for nonvalvular atrial fibrillation as an alternative to warfarin. There is a dearth of information regarding apixaban use in patients suffering from atrial fibrillation with intracardiac foreign bodies such as pacemaker leads. In this report, we describe a 72-year-old female patient with a complaint of weakness in both legs of a few days’ duration. She was detected to have a thrombus over the pacemaker lead and inside the left atrial appendage during apixaban treatment. After the discontinuation of apixaban and the commencement of warfarin, the thrombus was resolved. Our case is the first report to show that apixaban treatment (5 mg, twice daily) may not prevent the development of pacemaker lead thrombosis in patients with atrial fibrillation. © 2019, Tehran Heart Center. All rights reserved.en_US
dc.identifier.doi10.18502/jthc.v14i4.2005
dc.identifier.endpage186en_US
dc.identifier.issn1735-8620
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85075885600en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage183en_US
dc.identifier.urihttps://doi.org/10.18502/jthc.v14i4.2005
dc.identifier.urihttps://hdl.handle.net/20.500.14619/9095
dc.identifier.volume14en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherTehran Heart Centeren_US
dc.relation.ispartofJournal of Tehran University Heart Centeren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectApixabanen_US
dc.subjectArtificialen_US
dc.subjectAtrial fibrillationen_US
dc.subjectPacemakeren_US
dc.subjectThrombosisen_US
dc.titleDevelopment of pacemaker lead thrombosis in a patient with atrial fibrillation during apixaban treatmenten_US
dc.typeArticleen_US

Dosyalar